U.S. factory shuts down production of AstraZeneca vaccine

Source : 112 Ukraine

Emergent BioSolutions is going to switch to producing its own vaccine
13:43, 5 April 2021

Open source

Emergent BioSolutions factory, which belongs to Johnson & Johnson company stopped production of AstraZeneca vaccine. New York Times reported that, citing the company's statement. 

From now on, the plant will be producing its own vaccine. This step was made in order to avoid last week's mistake; 15,000,000 doses of the vaccine were rejected as defective when workers of the factory mixed Johnson&Johnson vaccine with another drug. The produced vaccine ceased to meet the requirement and was not authorized for use.

Johnson & Johnson took the full responsibility for the incident.

Related: Britain reports 30 cases of blood clots after AstraZeneca vaccine

Over the last 24 hours, Ukrainian doctors detected 10,179 new cases of infection with coronavirus; 254 people passed away. Maksym Stepanov, the Healthcare Minister reported that on Facebook.

On Sunday, the largest numbers of cases were observed in Kharkiv (1,155), Lviv (1,121), Dnipropetrovsk (1,003), Odesa (660) and Kyiv regions (619).

3,275 people were taken to hospitals during the previous 24 hours. 4,946 patients recovered from coronavirus.

Related: Seven UK citizens who received AstraZeneca vaccine die from blood clots

Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more
latest news
editor's choice